Tocqueville Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.76M Buy
21,433
+203
+1% +$69.5K 0.1% 175
2026
Q1
$7.47M Sell
21,230
-690
-3% -$246K 0.11% 179
2025
Q4
$7.17M Buy
21,920
+550
+3% +$174K 0.1% 177
2025
Q3
$6.03M Sell
21,370
-704
-3% -$204K 0.09% 203
2025
Q2
$6.16M Buy
22,074
+1,274
+6% +$361K 0.09% 195
2025
Q1
$6.48M Buy
20,800
+658
+3% +$194K 0.11% 165
2024
Q4
$5.25M Sell
20,142
-85
-0.4% -$25.2K 0.08% 178
2024
Q3
$6.52M Sell
20,227
-1,200
-6% -$393K 0.1% 162
2024
Q2
$6.69M Sell
21,427
-317
-1% -$93.1K 0.11% 155
2024
Q1
$6.18M Sell
21,744
-58
-0.3% -$17K 0.1% 166
2023
Q4
$6.28M Sell
21,802
-1,049
-5% -$286K 0.11% 158
2023
Q3
$6.14M Sell
22,851
-505
-2% -$126K 0.12% 163
2023
Q2
$5.19M Sell
23,356
-271
-1% -$62.9K 0.09% 174
2023
Q1
$5.71M Sell
23,627
-139
-0.6% -$34.1K 0.11% 172
2022
Q4
$6.24M Sell
23,766
-396
-2% -$106K 0.12% 170
2022
Q3
$5.45M Sell
24,162
-4,000
-14% -$970K 0.11% 171
2022
Q2
$6.85M Sell
28,162
-793
-3% -$194K 0.13% 171
2022
Q1
$7M Buy
28,955
+547
+2% +$126K 0.11% 185
2021
Q4
$6.39M Sell
28,408
-1,585
-5% -$335K 0.09% 212
2021
Q3
$6.38M Sell
29,993
-107
-0.4% -$24.6K 0.09% 209
2021
Q2
$7.34M Buy
30,100
+105
+0.4% +$25.8K 0.11% 209
2021
Q1
$7.46M Sell
29,995
-614
-2% -$147K 0.11% 199
2020
Q4
$7.04M Sell
30,609
-1,072
-3% -$247K 0.12% 196
2020
Q3
$8.05M Sell
31,681
-812
-2% -$201K 0.15% 142
2020
Q2
$7.66M Sell
32,493
-2,478
-7% -$565K 0.16% 142
2020
Q1
$7.09M Sell
34,971
-4,638
-12% -$1.01M 0.18% 126
2019
Q4
$9.55M Sell
39,609
-41,421
-51% -$9.13M 0.14% 164
2019
Q3
$15.7M Buy
81,030
+16,617
+26% +$3.19M 0.21% 132
2019
Q2
$11.9M Sell
64,413
-2,156
-3% -$386K 0.15% 171
2019
Q1
$12.6M Buy
66,569
+11
+0% +$2.1K 0.17% 153
2018
Q4
$13M Buy
66,558
+2,388
+4% +$466K 0.19% 136
2018
Q3
$13.3M Sell
64,170
-29,652
-32% -$5.84M 0.17% 155
2018
Q2
$17.3M Sell
93,822
-655
-0.7% -$116K 0.22% 119
2018
Q1
$16.1M Buy
94,477
+15,465
+20% +$2.84M 0.21% 134
2017
Q4
$13.7M Buy
79,012
+510
+0.6% +$90.3K 0.16% 164
2017
Q3
$14.6M Sell
78,502
-9,791
-11% -$1.73M 0.17% 160
2017
Q2
$15.2M Buy
88,293
+686
+0.8% +$112K 0.18% 153
2017
Q1
$14.4M Buy
87,607
+1,272
+1% +$211K 0.18% 162
2016
Q4
$12.6M Buy
86,335
+7,014
+9% +$1.06M 0.16% 171
2016
Q3
$13.2M Buy
79,321
+300
+0.4% +$50.7K 0.16% 166
2016
Q2
$12M Sell
79,021
-15
-0% -$2.33K 0.14% 169
2016
Q1
$11.8M Buy
79,036
+875
+1% +$130K 0.16% 161
2015
Q4
$12.7M Buy
78,161
+1,985
+3% +$312K 0.17% 159
2015
Q3
$10.5M Sell
76,176
-425
-0.6% -$67K 0.14% 188
2015
Q2
$11.8M Buy
76,601
+690
+0.9% +$111K 0.14% 190
2015
Q1
$12.1M Sell
75,911
-1,130
-1% -$178K 0.14% 180
2014
Q4
$12.3M Buy
77,041
+2,272
+3% +$354K 0.13% 192
2014
Q3
$10.5M Buy
74,769
+10,605
+17% +$1.38M 0.12% 194
2014
Q2
$7.59M Buy
64,164
+25,293
+65% +$2.93M 0.07% 250
2014
Q1
$4.79M Sell
38,871
-3,329
-8% -$404K 0.06% 261
2013
Q4
$4.81M Buy
42,200
+8,404
+25% +$956K 0.06% 262
2013
Q3
$3.78M Sell
33,796
-1,261
-4% -$137K 0.05% 337
2013
Q2
$3.46M Buy
+35,057
New +$3.64M 0.05% 338

Other funds holding AMGN

Tocqueville Asset Management's AMGN Position: Q2 2026 in Review

Tocqueville Asset Management increased its Amgen (AMGN) stake by 0.96% in Q2 2026, buying an estimated $69.5K and bringing the position to 21,433 shares worth $7.76M. The position accounts for 0.1% of the portfolio, ranked #175.

Tocqueville Asset Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.3M in Q2 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tocqueville Asset Management held 21,433 shares of Amgen worth $7.76M as of Q2 2026.
  • Tocqueville Asset Management bought 203 Amgen shares in Q2 2026, an estimated $69.5K.
  • Amgen made up 0.1% of Tocqueville Asset Management's portfolio in Q2 2026, its #175 holding.
  • Tocqueville Asset Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Amgen position peaked at $17.3M in Q2 2018.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.